Cassava Sciences Aktie: 12,37 Prozent Minus auf 1,03 Euro
Die Biotech-Aktie Filana Therapeutics, früher Cassava Sciences, verliert am Donnerstag deutlich an Wert. Das Papier fällt um 12,37 Prozent auf 1,03 Euro. Ein klarer Auslöser für den Rutsch blieb am…
Read the full articlede
You might also wanna read
Strategy比特币出售扰动市场，渣打仍坚持年末10万美元目标
PANews·8m ago
MiCA licensing only the beginning as crypto custodians face scrutiny
Cointelegraph·8m ago
UK financial regulators to begin overseeing Critical Third Parties announced by Treasury
Financial Conduct Authority·9m ago
Bitcoin is “A Screaming Buy”: Standard Chartered Backs $100,000 Target, Shrugs Off Strategy (MSTR) Sell-Off
Bitcoin Magazine·13m ago
TSMC’s Photonic Ramp Could Be the Quiet Catalyst in AI Chips
24/7 Wall St.·16m ago
Jemal Equities Refinances D.C. Office Building With $27M CMBS Loan
Commercial Observer·19m ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.